Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Roza Hayduk"'
Autor:
Ilya Lipkovich, Christopher Carlson, Gopalan Sethuraman, Paul S. Aisen, Hong Liu-Seifert, Karen C. Holdridge, Sharon L. Hoog, Rachelle S. Doody, Roza Hayduk, Scott W. Andersen, Eric Siemers
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Solanezumab is an anti-amyloid monoclonal antibody in clinical testing for treatment of Alzheimer's disease (AD). Its mechanism suggests the possibility of slowing the progression of AD. Methods A possible disease-modifying effect of sol
Publikováno v:
Psychopharmacology. 167:380-385
Modafinil is a first-line wake-promoting medication and a useful therapeutic alternative to psychostimulant medications for excessive daytime sleepiness.This 5-week, randomized, open-label study evaluated three strategies for switching patients from
Autor:
Tamsin L. Kelly, Alexandre Barbault, Daniel F. Kripke, Roza Hayduk, Boris Pasche, David Ryman
Publikováno v:
Stress Medicine. 13:251-258
Shift work and jet lag can disrupt circadian rhythms, with detrimental effects on alertness, performance and sleep. This study examined the effects of two interventions to adapt circadian rhythms, sleep and performance to a 10-h phase delay of the wo
Autor:
Alexandre Barbault, Niels Kuster, Martin Reite, Merrill M. Mitler, Lisa Higgs, Jean-Pierre Lebet, Claude Rossel, Roza Hayduk, Boris Pasche, David A. Amato, Milton K. Erman, Urania Dafni
Publikováno v:
Europe PubMed Central
The treatment of chronic psychophysiological insomnia presents a challenge that has not been met using currently available pharmacotherapy. Low energy emission therapy (LEET) has been developed as a potential alternative therapy for this disorder. LE
Autor:
Merrill M. Mitler, James C. Miller, Roza Hayduk, Denis F. Darko, Tamsin Kelly, Stephen J. Brown, Jeannine L. White
Publikováno v:
AIDS. 9:1043-1050
Objective : To repeat and extend findings suggesting that sleep disturbance, excessive daytime sleepiness, and degraded cognitive-motor abilities may be early markers of central nervous system (CNS) involvement in HIV infection. Design : A controlled
Autor:
Thomas Roth, Gwendolyn E Niebler, Russell Rosenberg, Keith Wesnes, John R. Harsh, Roza Hayduk, Sanjay Arora, James K. Walsh
Publikováno v:
Current medical research and opinion. 22(4)
This study assessed the efficacy and safety of armodafinil, the longer half-life enantiomer of modafinil, for the treatment of excessive sleepiness in patients with narcolepsy.This was a multicenter double-blind study with 196 patients (aged 18-65 ye
Publikováno v:
Sleep medicine. 1(1)
Background: Narcolepsy, a neurological disorder characterized by excessive daytime sleepiness and abnormal REM sleep, is known to be tightly associated with the human leukocyte antigen (HLA) DQB1*0602.Methods: In this study, baseline data collected f
Publikováno v:
Sleep.
Narcolepsy is a sleep disorder associated with HLA DR15 (DR2) and DQB1*0602. We HLA typed 509 patients enrolled in a clinical trial for the drug modafinil and analyzed the results in relation to cataplexy, a symptom of narcolepsy characterized by mus
Autor:
Eric Siemers, Joonmi Oh, Ann Marie Hake, Joyce Suhy, Roza Hayduk, Jerome Barakos, Christopher Carlson, Michael Case
Publikováno v:
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction Solanezumab, a humanized monoclonal antibody that binds soluble amyloid beta peptide, is being developed for treatment of Alzheimer's disease (AD). Methods Patients (n = 2042) with mild and moderate AD were randomized 1:1 to 400-mg solan
Publikováno v:
Psychopharmacology. 2003, Vol. 167 Issue 4, p380. 6p. 1 Diagram, 2 Charts.